A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy

The muscular dystrophies are a broad group of hereditary muscle diseases with variable severity. Population-based prevalence estimates have been reported but pooled estimates are not available. We performed a systematic review of worldwide population-based studies reporting muscular dystrophies prevalence and/or incidence using MEDLINE and EMBASE databases. The search strategy included key terms related to muscular dystrophies, incidence, prevalence and epidemiology. Two reviewers independently reviewed all abstracts, full text articles and abstracted data using standardized forms. Pooling of prevalence estimates was performed using random effect models. 1104 abstracts and 167 full text articles were reviewed. Thirty-one studies met all eligibility criteria and were included in the final analysis. The studies differed widely in their approaches to case ascertainment, resulting in significant methodological heterogeneity and varied data quality. The pooled prevalence of DMD and BMD was 4.78 (95% CI 1.94-11.81) and 1.53 (95% CI 0.26-8.94) per 100,000 males respectively. The incidence of DMD ranged from 10.71 to 27.78 per 100,000. This is the first meta-analysis of worldwide prevalence estimates for muscular dystrophies. There is a need for more epidemiological studies addressing global estimates on incidence and prevalence of muscular dystrophies, utilizing standardized diagnostic criteria as well as multiple sources of case ascertainment.

[1]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[2]  P. Beighton,et al.  Duchenne and Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected. , 1994, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[3]  David T. Okou,et al.  Microarray‐based mutation detection in the dystrophin gene , 2008, Human mutation.

[4]  Emery Diagnostic Criteria for Neuromuscular Disorders , 1997 .

[5]  N. Nevin,et al.  The prevalence of inherited neuromuscular disease in Northern Ireland , 1996, Neuromuscular Disorders.

[6]  I. Talvik,et al.  A descriptive epidemiological study of Duchenne muscular dystrophy in childhood in Estonia. , 2003, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[7]  E. Khedr,et al.  Epidemiological Study of Muscular Disorders in Assiut, Egypt , 2005, Neuroepidemiology.

[8]  S. Pandya,et al.  Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007. , 2009, MMWR. Morbidity and mortality weekly report.

[9]  C. Greenberg,et al.  GENE STUDIES IN NEWBORN MALES WITH DUCHENNE MUSCULAR DYSTROPHY DETECTED BY NEONATAL SCREENING , 1988, The Lancet.

[10]  A. Green,et al.  The Duchenne muscular dystrophy population in Denmark, 1977–2001: prevalence, incidence and survival in relation to the introduction of ventilator use , 2003, Neuromuscular Disorders.

[11]  D. Zwijnenburg,et al.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.

[12]  Michael H. Boyle,et al.  Guidelines for evaluating prevalence studies , 1998 .

[13]  M. Osame,et al.  Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques. , 1991, Neuroepidemiology.

[14]  A. Emery Population frequencies of inherited neuromuscular diseases—A world survey , 1991, Neuromuscular Disorders.

[15]  K. Bushby,et al.  Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. , 2009, Brain : a journal of neurology.

[16]  N. Darín,et al.  Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden , 2000, Neuromuscular Disorders.

[17]  Hude Quan,et al.  Recommendations for optimal ICD codes to study neurologic conditions , 2012, Neurology.

[18]  V. Wong,et al.  Prevalence of Neuromuscular Diseases in Chinese Children: A Study in Southern China , 2003, Journal of child neurology.

[19]  Zhujun Zhang,et al.  Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center , 2010, Journal of Human Genetics.

[20]  A. McCormick,et al.  A Population-Based Study of Dystrophin Mutations in Canada , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[21]  R. Gelber,et al.  Meta-analysis: the fashion of summing-up evidence. Part I. Rationale and conduct. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  P. Thomas,et al.  Classification of neuromuscular diseases , 1988, Journal of the Neurological Sciences.

[23]  L. Murri,et al.  Epidemiology of dystrophinopathies in North‐West Tuscany: a molecular genetics‐based revisitation , 1999, Clinical genetics.

[24]  M. Thambyayah,et al.  Prevalence and incidence of Becker muscular dystrophy , 1991, The Lancet.